Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia - Related Studies

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00003727. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Myelogenous, Chronic, BCR-ABL Positive
		Leukemia, Myeloid

3	More general conditions related to this trial
		Bone Marrow Diseases
		Hematologic Diseases
		Myeloproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		carmustine
		cyclophosphamide
		etoposide
		filgrastim
		gemcitabine hydrochloride
		melphalan
		recombinant interferon alfa
		sargramostim
		therapeutic autologous lymphocytes

5	Additional drug interventions recognized in this trial
		Gemcitabine
		Interferon Alfa-2a
		Interferon Type I, Recombinant
		Interferon-alpha
		Interferons

6	More general drug interventions related to this trial
		Alkylating Agents
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Antiviral Agents
		Enzyme Inhibitors
		Growth Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		University of Maryland Greenebaum Cancer Center